Patient Capital Management, LLC: NVIDIA CORPORATION COM (NVDA): Quarterly 13F Position History
As of Q1 2026, Patient Capital Management, LLC reported 711,115 shares of NVIDIA CORPORATION COM (NVDA), worth $124.0M and representing 4.6% of its 13F equity book. Quarter-over-quarter share count change: + 72,301 (+11.3%) . The position first appeared in Q1 2024 and has been disclosed across 9 13F-HR filings in Pactolio's tracked window.
- 711,115Shares Held (Latest Filing)
- $124.0MReported Market Value (Latest Filing)
- 4.6%Portfolio Weight (% of 13F Equity Book)
- +72,301Quarter-over-Quarter Share Change
- +$4.9MQuarter-over-Quarter Value Change
- 711,115Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 9 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 711,115 | +72,301 | +11.3% | $124.0M | 4.6% | $174.4 |
| Q4 2025 | 638,814 | +6,130 | +1.0% | $119.1M | 4.6% | $186.5 |
| Q3 2025 | 632,684 | 1,489 | -0.2% | $118.0M | 4.7% | $186.6 |
| Q2 2025 | 634,173 | +7,221 | +1.2% | $100.2M | 4.5% | $158.0 |
| Q1 2025 | 626,952 | +18,389 | +3.0% | $67.9M | 3.5% | $108.4 |
| Q4 2024 | 608,563 | 165 | -0.0% | $81.7M | 3.8% | $134.3 |
| Q3 2024 | 608,728 | +2,889 | +0.5% | $73.9M | 3.6% | $121.4 |
| Q2 2024 | 605,839 | +545,233 | +899.6% | $74.8M | 4.0% | $123.5 |
| Q1 2024 | 60,606 | — | — | $54.8M | 2.7% | $903.6 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Patient Capital Management, LLC first disclose a NVDA position in 13F-HR filings?
Patient Capital Management, LLC first reported NVIDIA CORPORATION COM (NVDA) on its 13F-HR filing for the period ending 2024-03-31 (Q1 2024). The position has appeared on 9 reported quarters within Pactolio's tracked window.
What was Patient Capital Management, LLC's most recent quarter-over-quarter share-count change in NVDA?
Between Q4 2025 and Q1 2026, Patient Capital Management, LLC added 72,301 shares of NVDA (+11.3%), bringing the total reported position to 711,115 shares at a market value of $124.0M.
Does the implied price-per-share represent Patient Capital Management, LLC's cost basis in NVDA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.